CME Group vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 69)

CME Group

LeaderConsumer Finance

Enterprise

Chicago global derivatives exchange (NASDAQ: CME) at $99B market cap; XRP futures launched May 2025 on CFTC commodity approval, expanding crypto suite with Bitcoin/Ethereum/Solana competing with ICE for institutional derivatives volume.

AI VisibilityBeta
Overall Score
B69
Category Rank
#130 of 290
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
66
Perplexity
66
Gemini
70

About

CME Group Inc. is a Chicago, Illinois-based global derivatives exchange operator — publicly traded on NASDAQ (NASDAQ: CME) as an S&P 500 component — operating the world's largest and most diverse derivatives marketplace with a market capitalization of approximately $99 billion and annual revenue exceeding $6 billion, serving customers in approximately 150 countries through nearly 24-hour electronic trading via the CME Globex platform. CME Group operates four major exchanges: the Chicago Mercantile Exchange (CME, founded 1898), Chicago Board of Trade (CBOT, founded 1848), New York Mercantile Exchange (NYMEX), and Commodity Exchange Inc. (COMEX) — offering futures and options contracts across interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, and cryptocurrency. In May 2025, CME Group launched XRP futures following CFTC classification of XRP as a commodity, with first-day trading exceeding $19 million in notional volume across micro (2,500 XRP) and standard (50,000 XRP) contracts — expanding CME's cryptocurrency derivatives suite that already includes Bitcoin, Ethereum, and Solana futures. CME Group employs approximately 3,700 people.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

69
Overall Score
90
#130
Category Rank
#9
70
AI Consensus
60
stable
Trend
stable
66
ChatGPT
99
66
Perplexity
99
70
Gemini
83
77
Claude
96
65
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.